Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biohaven (BHVN) Current Assets (2021 - 2026)

Biohaven has reported Current Assets over the past 6 years, most recently at $385.6 million for Q1 2026.

  • Quarterly results put Current Assets at $385.6 million for Q1 2026, up 0.76% from a year ago — trailing twelve months through Mar 2026 was $385.6 million (up 0.76% YoY), and the annual figure for FY2025 was $368.3 million, down 31.6%.
  • Current Assets reached $385.6 million in Q1 2026 per BHVN's latest filing, up from $368.3 million in the prior quarter.
  • Across five years, Current Assets topped out at $587.0 million in Q4 2022 and bottomed at $80.6 million in Q3 2022.
  • Median Current Assets over the past 5 years was $434.1 million (2023), compared with a mean of $411.6 million.
  • The largest annual shift saw Current Assets soared 519.01% in 2022 before it plummeted 35.95% in 2024.
  • Over 5 years, Current Assets stood at $587.0 million in 2022, then fell by 24.62% to $442.4 million in 2023, then increased by 21.7% to $538.5 million in 2024, then tumbled by 31.6% to $368.3 million in 2025, then increased by 4.7% to $385.6 million in 2026.
  • Business Quant data shows Current Assets for BHVN at $385.6 million in Q1 2026, $368.3 million in Q4 2025, and $323.6 million in Q3 2025.